A RAPID PREADMISSION METHOD FOR PREDICTING INPATIENT COURSE OF DISEASE FOR PATIENTS WITH HIV-RELATED PNEUMOCYSTIS-CARINII PNEUMONIA

被引:42
作者
BENNETT, CL
WEINSTEIN, RA
SHAPIRO, MF
KESSLER, HA
DICKINSON, GM
PETERSON, B
COHN, SE
GEORGE, WL
GILMAN, SC
机构
[1] DURHAM VET ADM HOSP,DIV HLTH SERV RES,DURHAM,NC
[2] DUKE UNIV,DIV HEMATOL ONCOL,DURHAM,NC
[3] DUKE UNIV,CTR HLTH POLICY RES & EDUC,DURHAM,NC
[4] DUKE UNIV,DIV BIOSTAT,DURHAM,NC
[5] DUKE UNIV,DEPT MED,DURHAM,NC
[6] RUSH PRESBYTERIAN ST LUKES MED SCH,CHICAGO,IL
[7] UNIV ILLINOIS,URBANA,IL 61801
[8] UNIV ROCHESTER,ROCHESTER,NY
[9] UNIV MIAMI,MIAMI,FL 33152
[10] UNIV CALIF LOS ANGELES,LOS ANGELES,CA
[11] RAND CORP,SANTA MONICA,CA
[12] VET ADM MED CTR,WESTERN REG SPECIAL STUDIES GRP,LONG BEACH,CA 90822
[13] W LOS ANGELES VET AFFAIRS MED CTR,LOS ANGELES,CA 90073
关键词
D O I
10.1164/ajrccm.150.6.7952607
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Pneumocystis carinii pneumonia (FCP) has been the most common reason for hospitalization and the most common cause of death for persons with HIV infection. Hospital mortality rates for PCP range from 10 to 60%. Studies that evaluate differences in hospital mortality rates must control for differences in patient severity of illness. We developed a simple staging system for categorizing severity of illness in patients with PCP. We analyzed the relation between clinical factors and in-hospital mortality for 576 hospitalized patients with HIV-related PCP treated at 56 hospitals for the years 1987 to 1990. Four stages of PCP could be identified based on three routinely measured clinical variables: alveolar-arterial oxygen difference, total lymphocyte count, and body mass index. The mortality rate increased by stage: 1% for Stage 1, 8% for Stage 2, 23% for Stage 3, and 48% for Stage 4. The four-stage severity system compared well with previous models developed for AIDS and for PCP, and is easier to use in clinical practice. Our staging system identifies patients with a high and low risk of in-hospital death upon admission. Physicians may benefit from consideration of PCP stage in deciding on management strategies. In addition, researchers involved in clinical trials of new agents for FCP might consider stratification by PCP stage in order to define homogenous groups.
引用
收藏
页码:1503 / 1507
页数:5
相关论文
共 18 条
  • [1] IMPROVED OUTCOME OF PNEUMOCYSTIS-CARINII PNEUMONIA IN AIDS PATIENTS - A MULTIFACTORIAL TREATMENT EFFECT
    BECK, EJ
    FRENCH, PD
    HELBERT, MH
    ROBINSON, DS
    MOSS, FM
    HARRIS, JRW
    PINCHING, AJ
    MITCHELL, DM
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 1992, 3 (03) : 182 - 187
  • [2] EMPIRICALLY TREATED PNEUMOCYSTIS-CARINII PNEUMONIA IN LONDON, 1983-1989
    BECK, EJ
    FRENCH, PD
    HELBERT, MH
    ROBINSON, DS
    MOSS, FM
    HARRIS, JRW
    PINCHING, AJ
    MITCHELL, DM
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 1992, 3 (04) : 285 - 287
  • [3] THE RELATION BETWEEN HOSPITAL EXPERIENCE AND IN-HOSPITAL MORTALITY FOR PATIENTS WITH AIDS-RELATED PCP
    BENNETT, CL
    GARFINKLE, JB
    GREENFIELD, S
    DRAPER, D
    ROGERS, W
    MATHEWS, C
    KANOUSE, DE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (20): : 2975 - 2979
  • [4] BENNETT CL, 1992, J ACQ IMMUN DEF SYND, V5, P856
  • [5] COMBINED APACHE-II SCORE AND SERUM LACTATE-DEHYDROGENASE AS PREDICTORS OF IN-HOSPITAL MORTALITY CAUSED BY 1ST EPISODE PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    BENSON, CA
    SPEAR, J
    HINES, D
    POTTAGE, JC
    KESSLER, HA
    TRENHOLME, GM
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (02): : 319 - 323
  • [6] Blumberg M S, 1986, Med Care Rev, V43, P351, DOI 10.1177/107755878604300205
  • [8] PROGNOSTIC FACTORS AND LIFE EXPECTANCY OF PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME AND PNEUMOCYSTIS-CARINII PNEUMONIA
    BRENNER, M
    OGNIBENE, FP
    LACK, EE
    SIMMONS, JT
    SUFFREDINI, AF
    LANE, HC
    FAUCI, AS
    PARRILLO, JE
    SHELHAMER, JH
    MASUR, H
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 136 (05): : 1199 - 1206
  • [9] GUENTER P, 1993, J ACQ IMMUN DEF SYND, V6, P1130
  • [10] A NEW PROGNOSTIC STAGING SYSTEM FOR THE ACQUIRED IMMUNODEFICIENCY SYNDROME
    JUSTICE, AC
    FEINSTEIN, AR
    WELLS, CK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (21) : 1388 - 1393